New Efforts to Help Improve Medical Products for Patient Safety and Quality of Medical Care HHS Secretary Mike Leavitt today announced efforts underway at the U.S. Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS) that will complement … [Read more...] about FDA Sentinel Initiative — Information Management
FDA Press Release
FDA Obtains Permanent Injunction Against Scientific Laboratories
FDA News FOR IMMEDIATE RELEASE May 16, 2008 Media Inquiries: Rita Chappelle, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Obtains Permanent Injunction Against Scientific Laboratories, Inc. Company manufactures and distributes unapproved … [Read more...] about FDA Obtains Permanent Injunction Against Scientific Laboratories
Thromboembolic Events with Ortho Evra Contraceptive Patch
New Data on Thromboembolic Events with Ortho Evra Contraceptive Patch The prescribing information for the Ortho Evra Contraceptive Transdermal Patch is being updated with results of a new study on the risk of venous thromboembolism. This study found that women aged 15-44 who … [Read more...] about Thromboembolic Events with Ortho Evra Contraceptive Patch
Fentanyl (Duragesic) Patches Recalled
What are fentanyl skin patches? FENTANYL (Duragesic®, E-TRANS® Fentanyl) relieves moderate to severe chronic pain. Fentanyl patches are commonly used to treat pain associated with cancer. Once the patch is applied, the medicine is slowly absorbed through your skin into the … [Read more...] about Fentanyl (Duragesic) Patches Recalled
Adverse Reactions Linked to Botox Use
FDA Notifies Public of Adverse Reactions Linked to Botox Use Ongoing safety review of Botox, Botox Cosmetic and Myobloc taking place The U.S. Food and Drug Administration today notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum … [Read more...] about Adverse Reactions Linked to Botox Use